Literature DB >> 18206647

Cyclin E/Cdk2, P/CAF, and E1A regulate the transactivation of the c-myc promoter by FOXM1.

Inken Wierstra1, Jürgen Alves.   

Abstract

FOXM1c transactivates the c-myc promoter by binding directly to its TATA-boxes. The present study demonstrates that the transactivation of the c-myc promoter by FOXM1c is enhanced by the key proliferation signal cyclin E/Cdk2, but repressed by P/CAF and the adenoviral oncoprotein E1A. Furthermore, FOXM1c interacts with the coactivator and histone acetyltransferase P/CAF. This study shows that, on the c-myc-P1 TATA-box, FOXM1c does not function simply as normal transcription factor just binding to an unusual site. Moreover, the inhibitory N-terminus of FOXM1c does not inhibit its transrepression domain or its EDA. Others reported that a cyclin/Cdk-binding LXL-motif of the splice variant FoxM1b is required for its interaction with Cdk2, Cdk1, and p27, its phosphorylation by Cdk1 and its activation by Cdc25B. In contrast, we now demonstrate that this LXL-motif is not required for the activation of FOXM1c by cyclin D1/Cdk4, cyclin E/Cdk and cyclin A/Cdk2 or for the repression of FOXM1c by p27.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18206647     DOI: 10.1016/j.bbrc.2008.01.039

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  A novel function of the proneural factor Ascl1 in progenitor proliferation identified by genome-wide characterization of its targets.

Authors:  Diogo S Castro; Ben Martynoga; Carlos Parras; Vidya Ramesh; Emilie Pacary; Caroline Johnston; Daniela Drechsel; Mélanie Lebel-Potter; Laura Galinanes Garcia; Charles Hunt; Dirk Dolle; Angela Bithell; Laurence Ettwiller; Noel Buckley; François Guillemot
Journal:  Genes Dev       Date:  2011-05-01       Impact factor: 11.361

2.  The transcription factor FOXM1 is a cellular target of the natural product thiostrepton.

Authors:  Nagaratna S Hegde; Deborah A Sanders; Raphaël Rodriguez; Shankar Balasubramanian
Journal:  Nat Chem       Date:  2011-08-21       Impact factor: 24.427

Review 3.  Forkhead box M1 transcription factor: a novel target for cancer therapy.

Authors:  Zhiwei Wang; Aamir Ahmad; Yiwei Li; Sanjeev Banerjee; Dejuan Kong; Fazlul H Sarkar
Journal:  Cancer Treat Rev       Date:  2009-12-22       Impact factor: 12.111

4.  Everolimus (RAD001) inhibits the proliferation of rat vascular smooth muscle cells by up-regulating the activity of the p27/kip1 gene promoter.

Authors:  Boli Ran; Minfeng Li; Yeqing Li; Yang Lin; Weimin Liu; Qiulin Luo; Yongxin Fu; Qianmei Tang; Ya Yang; Yunfei Pu
Journal:  Anatol J Cardiol       Date:  2016-05-09       Impact factor: 1.596

5.  Dysregulation of miR-23b-5p promotes cell proliferation via targeting FOXM1 in hepatocellular carcinoma.

Authors:  Xinchen Yang; Shikun Yang; Jinhua Song; Wenjie Yang; Yang Ji; Feng Zhang; Jianhua Rao
Journal:  Cell Death Discov       Date:  2021-03-15

Review 6.  Looking into key bacterial proteins involved in gut dysbiosis.

Authors:  Xin-Yu Zeng; Ming Li
Journal:  World J Methodol       Date:  2021-07-20

7.  Identification of cell cycle-regulated genes periodically expressed in U2OS cells and their regulation by FOXM1 and E2F transcription factors.

Authors:  Gavin D Grant; Lionel Brooks; Xiaoyang Zhang; J Matthew Mahoney; Viktor Martyanov; Tammara A Wood; Gavin Sherlock; Chao Cheng; Michael L Whitfield
Journal:  Mol Biol Cell       Date:  2013-10-09       Impact factor: 4.138

8.  MiR-216b inhibits cell proliferation by targeting FOXM1 in cervical cancer cells and is associated with better prognosis.

Authors:  Shanyang He; Bing Liao; Yalan Deng; Chang Su; Jiuling Tuo; Jun Liu; Shuzhong Yao; Lin Xu
Journal:  BMC Cancer       Date:  2017-10-04       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.